Quanterix priced a planned public offering at $25.25 per share for a total of 2,376,238 shares of common stock. The company intends to use the proceeds to update and improve its Simoa instruments and technology, develop additional tests, broaden its life sciences operations, and for other purposes.
Public offering priced at $25.25 per share for Quanterix
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.